Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

532-12-7

Myosmine

532-12-7
5874-97-5

Metaproterenol Hemisulfate Salt

5874-97-5
51384-51-1

Metoprolol

51384-51-1
133073-73-1

Methotrexate H2O

133073-73-1
520-85-4

Medroxyprogesterone

520-85-4
595-33-5

Megestrol Acetate

595-33-5
85650-52-8

Mirtazapine

85650-52-8
4812-40-2

Metronidazole hydroxy

4812-40-2
7232-21-5

Metoclopramide HCl

7232-21-5
83-43-2

Methylprednisolon

83-43-2
71320-77-9

Moclobemid

71320-77-9
24280-93-1

Mycophenolic acid

24280-93-1
5466-77-3

2-Ethylhexyl-4-methoxycinnamat

5466-77-3
1722-62-9

Mepivacaine HCl

1722-62-9
56392-14-4

Metoprolol acid

56392-14-4
73-31-4

Melatonin

73-31-4
132-92-3

Methicillin sodium salt

132-92-3
35337-98-5

Monocrotaline N-oxide

35337-98-5
639-46-3

Morphine N-oxide

639-46-3
119478-56-7

Meropenem 3H2O

119478-56-7